These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12069568)

  • 1. The CONSORT statement: explanation and elaboration. Consolidated Standards of Reporting Trials.
    Kessler KM
    Ann Intern Med; 2002 Jun; 136(12):926-7; author reply 926-7. PubMed ID: 12069568
    [No Abstract]   [Full Text] [Related]  

  • 2. The CONSORT statement: explanation and elaboration. Consolidated Standards of Reporting Trials.
    Yuasa H
    Ann Intern Med; 2002 Jun; 136(12):926-7; author reply 926-7. PubMed ID: 12069567
    [No Abstract]   [Full Text] [Related]  

  • 3. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Consolidated Standards of Reporting Trials (CONSORT): better presentation of surgical trials in the Journal of Hand Surgery.
    Sauerland S; Davis TR
    J Hand Surg Br; 2004 Dec; 29(6):621-4. PubMed ID: 15542227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
    Altman DG; Schulz KF; Moher D; Egger M; Davidoff F; Elbourne D; Gøtzsche PC; Lang T;
    Ann Intern Med; 2001 Apr; 134(8):663-94. PubMed ID: 11304107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT).
    Smith BA; Lee HJ; Lee JH; Choi M; Jones DE; Bausell RB; Broome ME
    Nurs Outlook; 2008; 56(1):31-37. PubMed ID: 18237622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials.
    Moher D
    JAMA; 1998 May; 279(18):1489-91. PubMed ID: 9600488
    [No Abstract]   [Full Text] [Related]  

  • 9. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The CONSORT statement (CONsolidated Standards Of Reporting Trials)].
    Lorette G; Maruani A
    Ann Dermatol Venereol; 2013; 140(6-7):431-5. PubMed ID: 23773740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.
    Schulz KF; Altman DG; Moher D;
    Ann Intern Med; 2010 Jun; 152(11):726-32. PubMed ID: 20335313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.
    Gagnier JJ; Boon H; Rochon P; Moher D; Barnes J; Bombardier C;
    Ann Intern Med; 2006 Mar; 144(5):364-7. PubMed ID: 16520478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quality of safety reporting in trials is still suboptimal: survey of major general medical journals.
    Haidich AB; Birtsou C; Dardavessis T; Tirodimos I; Arvanitidou M
    J Clin Epidemiol; 2011 Feb; 64(2):124-35. PubMed ID: 21172601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated Consolidated Standards of Reporting Trials (CONSORT): it just gets better.
    Boers M
    J Clin Epidemiol; 2010 Aug; 63(8):813-4. PubMed ID: 20346626
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving the quality of reporting alcohol outcome studies: effects of the CONSORT statement.
    Ladd BO; McCrady BS; Manuel JK; Campbell W
    Addict Behav; 2010 Jul; 35(7):660-6. PubMed ID: 20207490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying the CONSORT and STROBE statements to evaluate the reporting quality of neovascular age-related macular degeneration studies.
    Fung AE; Palanki R; Bakri SJ; Depperschmidt E; Gibson A
    Ophthalmology; 2009 Feb; 116(2):286-96. PubMed ID: 19091408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The REFLECT statement: reporting guidelines for Randomized Controlled Trials in livestock and food safety: explanation and elaboration.
    Sargeant JM; O'Connor AM; Gardner IA; Dickson JS; Torrence ME;
    Zoonoses Public Health; 2010 Mar; 57(2):105-36. PubMed ID: 20070652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herbal CONSORT statement and standardization of reporting traditional Chinese drug trials].
    Fei YT; Liu JP
    Zhongguo Zhong Yao Za Zhi; 2008 Jan; 33(1):89-94. PubMed ID: 18338628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT.
    Dean ME; Coulter MK; Fisher P; Jobst K; Walach H
    Homeopathy; 2007 Jan; 96(1):42-5. PubMed ID: 17227747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CONSORT statement: will it lead to improved reporting of clinical trials in ophthalmology? Consolidated Standards of Reporting Trials.
    Hawkins BS
    Arch Ophthalmol; 1999 May; 117(5):677-80. PubMed ID: 10326970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.